Pharma News

The latest developments from pharmaceutical and biopharmaceutical companies, both innovator and generic-drug companies, and leading regulatory news.

Johnson & Johnson is one of 26 companies to join a new federal initiative, Supplier Pay, a new partnership with the private sector to strengthen small businesses by increasing their working capital. The program was announced by the White...

Novartis has announced a collaboration with the Banner Alzheimer's Institute (BAI) on a clinical study in Alzheimer's disease (AD) prevention. The study will determine whether two Novartis investigational anti-amyloid treatments can prevent or...

Novartis announced that its eye care division Alcon has entered into an agreement with a division of Google Inc. to in-license its "smart lens" technology for all ocular medical uses. The agreement with Google[x], a team within Google that is...

Actavis plc has filed an abbreviated new drug application (ANDA) with the US Food and Drug Administration (FDA) seeking approval to market doxylamine succinate and pyridoxine hydrochloride delayed-release tablets, 10 mg/10 mg. Actavis' ANDA...

Teva Pharmaceuticals Industries Ltd. reports that the US Food and Drug Administration (FDA) has accepted for review the company's new drug application (NDA) for albuterol multi-dose dry-powder inhaler (MDPI), an investigational...

Baxter International Inc. has appointed John Orloff, MD, as vice president and global head of research and development for Baxter BioScience, effective immediately. Orloff joins Baxter from Merck Serono Pharmaceuticals, where he served as global...

Baxter International Inc. has acquired AesRx, LLC, a private US biopharmaceutical company focused on orphan drug targets, including the development and commercialization of Aes-103, an investigational prophylactic treatment for sickle-cell...

Baxter International Inc. reports that upon completion of the tax-free distribution of the company's biopharmaceuticals business, Robert J. Hombach, currently chief financial officer for Baxter International Inc., will be appointed chief financial...

Bausch + Lomb is voluntarily recalling 849,044 tubes of an ophthalmic ointment due to crystal precipitate formation and an increase in the number of complaints associated with a gritty, sand-like feeling in the eye. The affected product is...